FDA Moving To E-Filing - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IoT
IoT
Feature
News
2/21/2002
01:50 PM
50%
50%

FDA Moving To E-Filing

Search-and-retrieval app tracks drug reports.

The U.S. Food & Drug Administration is pushing the food and drug manufacturers it regulates to make greater use of electronic document filing. As part of this effort, the FDA's own Center for Drug Evaluation and Research this month implemented search-and-retrieval software to help it better manage the electronic submission of reports about negative reactions to pharmaceuticals.

Medical professionals submit on average 300,000 adverse-event reports annually to the FDA, says Randy Levin, the center's associate director for information management. These reports contain information about patients who've had adverse reactions to commercially available drugs. The FDA collects the data from these reports in its Adverse Event Reporting System, which uses an Oracle7 database to manage about 2.5 million documents.

The FDA's drug-evaluation center implemented RetrievalWare search software from Convera Corp. The center joins the rest of the FDA in using the search software, which helps more than 1,800 scientists access the database. The FDA also uses the RetrievalWare search-and-retrieval engine in areas such as food safety and veterinary medicine.

The system lets drug-safety evaluators and epidemiologists sort through data stored in file servers, groupware systems, relational databases, document-management systems, and Web servers. The FDA can then disseminate this data to doctors and pharmacists via E-mail or post the information to the FDA site.

The drug-evaluation center's scientists will use RetrievalWare to search not only adverse event reports, but also archives of documents related to the approval, labeling, and marketing of new drugs, says Roger Goetsch, a manager with the FDA's Office of Drug Safety.

FDA regulation 21 (Code of Federal Regulations Part 11) lays the foundation for pharmaceutical and food companies to be able to accept, secure, and store digital signatures and electronic records (see "Lilly Cures Inefficiency With IT," Feb. 18, p. 42). Although the FDA hasn't yet made electronic submissions mandatory, it's "an important initiative that lets the government handle the complex health and safety challenges of the 21st century," ARC Advisory Group analyst John Blanchard says.

Drug research is expected to accelerate as companies increasingly rely on technology to automate drug discovery and testing. So, too, will the federal government turn to technology to help it more efficiently regulate and monitor the growing pharmaceuticals and biotech industries.

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
Comment  | 
Print  | 
More Insights
The State of Cloud Computing - Fall 2020
The State of Cloud Computing - Fall 2020
Download this report to compare how cloud usage and spending patterns have changed in 2020, and how respondents think they'll evolve over the next two years.
News
How to Create a Successful AI Program
Jessica Davis, Senior Editor, Enterprise Apps,  10/14/2020
News
Think Like a Chief Innovation Officer and Get Work Done
Joao-Pierre S. Ruth, Senior Writer,  10/13/2020
Slideshows
10 Trends Accelerating Edge Computing
Cynthia Harvey, Freelance Journalist, InformationWeek,  10/8/2020
Register for InformationWeek Newsletters
Video
Current Issue
[Special Report] Edge Computing: An IT Platform for the New Enterprise
Edge computing is poised to make a major splash within the next generation of corporate IT architectures. Here's what you need to know!
White Papers
Slideshows
Twitter Feed
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.
Sponsored Video
Flash Poll